Vinay Modgil

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Escherichia Coli

Urinary Tract Infection

Top Venues

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Harpreet Kaur, Naveen Chaudhary, Vinay Modgil, Manmohit Kalia, Vishal Kant, Balvinder Mohan, Alka Bhatia, Neelam Taneja
In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli . Antibiotics (Basel, Switzerland) 12 (1) (2023)
Harpreet Kaur, Naveen Chaudhary, Vinay Modgil, Manmohit Kalia, Vishal Kant, Balvinder Mohan, Alka Bhatia, Neelam Taneja
In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli . Antibiotics (Basel, Switzerland) 12 (1) (2023)
Naveen Chaudhary, Balvinder Mohan, Harpreet Kaur, Vinay Modgil, Vishal Kant, Alka Bhatia, Neelam Taneja
Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model. Antibiotics (Basel, Switzerland) 12 (6) (2023)
Naveen Chaudhary, Balvinder Mohan, Harpreet Kaur, Vinay Modgil, Vishal Kant, Alka Bhatia, Neelam Taneja
Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model. Antibiotics (Basel, Switzerland) 12 (6) (2023)
Harpreet Kaur, Vinay Modgil, Naveen Chaudhary, Balvinder Mohan, Neelam Taneja
Computational Guided Drug Targets Identification against Extended-Spectrum Beta-Lactamase-Producing Multi-Drug Resistant Uropathogenic Escherichia coli . Biomedicines 11 (7) (2023)